Clinical and epidemiological features of visceral leishmaniasis and Hiv Co-infection in fifteen patients from Brazil

Journal of Parasitology

Volumn 95, Issue 3, 2009, Pages 652-655

  Daher, E F ^a   Fonseca, P P ^a   Gerhard, E S ^a   Silva Leitao T M J ^a,b   Silva Junior, G B ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Hospital Sao Jose de Doencas Infecciosas   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; MEGLUMINE ANTIMONATE; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ENDEMISM; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIASIS; SYMPTOM;

ARTICLE; ASTHENIA; BONE MARROW BIOPSY; BRAZIL; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COUGHING; DIAGNOSTIC ACCURACY; DIARRHEA; DRUG TREATMENT FAILURE; FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MIXED INFECTION; MORTALITY; OPPORTUNISTIC INFECTION; PANCYTOPENIA; RECOMMENDED DRUG DOSE; RELAPSE; RURAL AREA; SEPTIC SHOCK; SEX DIFFERENCE; SPLENOMEGALY; TREATMENT OUTCOME; TREATMENT RESPONSE; URBAN AREA; VIRUS LOAD; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION; ADULT; AIDS RELATED COMPLEX; BONE MARROW; FEMALE; MALE; MIDDLE AGED; PARASITOLOGY; RETROSPECTIVE STUDY; TIME;

BRAZIL; SOUTHERN EUROPE;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASTHENIA; BONE MARROW; BRAZIL; CD4 LYMPHOCYTE COUNT; COUGH; DIARRHEA; FEMALE; FEVER; HIV INFECTIONS; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PANCYTOPENIA; RETROSPECTIVE STUDIES; SPLENOMEGALY; TIME FACTORS; WEIGHT LOSS;

EID: 73949083849     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1678.1     Document Type: Article

References (32)

1. ALVAR, J., C. CANAVATE, B. GUTIÉRREZ- SOLAR, M. JIMÉNEZ, F. LAGUNA, R. LÓPEZ-VÉLEZ, R. MOLINA, AND J. MORENO. 1997. Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clinical Microbiology Review 10: 298-318.
2. BASSET D., F. FARAUT, P. MARTY, J. DEREURE, E. ROSENTHAL, C. MARY, F. PRATLONG, L. LACHAUD, P. BASTIEN, AND J. P. DEDET. 2005. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes and Infection 7: 1370-1375.
3. BORGES, A. S., M. S. FERREIRA, M. T. A. SILVESTRE, S. A. NISHIOKA, AND A. ROCHA. 1997. Histoplasmose em pacientes imunodeprimi-dos: Estudo de 18 casos observados em Uberlândia, MG. Revista da Sociedade Brasileira de Medicina Tropical 30: 119-124.
4. CENTERS FOR DISEASE CONTROL AND PREVENTION. 1987. Revision of the CDC case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 36(Suppl. 1S): 12S.
5. DANTAS-TORRES, F., AND S. P. BRANDÃO-FILHO. 2006. Geographical expansion of visceral leishmaniasis in the State of Pernambuco. Re-vista da Sociedade Brasileira de Medicina Tropical 39: 352-356.
6. DEDET, J. P., AND F. PRATLONG. 2000. Leishmania, Trypanosoma and monoxenous trypanosomatids as emerging opportunistic agents. Journal of Eukaryotic Microbiology 47: 37-39.
7. DUJARDIN, J. C. 2006. Risk factors in the spread of leishmaniases: Towards integrated monitoring? Trends in Parasitology 22: 4-6.
8. FERNANDEZ-GUERRERO, M. L., P. ROBLES, P. RIVAS, F. MOJER, G. MUÑIZ, AND M. DE GÓRGOLAS. 2004. Visceral leishmaniasis in immuno-compromised patients with and without AIDS: A comparison of clinical features and prognosis. Acta Tropica 90: 11-16.
9. GALLARDO, J. A., J. A. PINEDA, J. MACIAS, R. TORRONTERAS, AND E. LISSEN. 1996. Specificity of a commercial indirect immunofluores-cence technique in the diagnosis of visceral leishmaniasis in patients with HIV-1. Transactions of the Royal Society of Tropical Medicine and Hygiene 90: 383.
10. GOLDANI, L. Z., R. MARTINEZ, G. A. LANDELL, A. A. MACHADO, AND V. COUTINHO. 1989. Paracoccidioidomycosis in a patient with acquired immunodeficiency syndrome. Mycopathologia 105: 71-74.
11. GUERIN, P. J., P. OLLIARO, S. SUNDAR, M. BODAERT, S. L. CRAFT, P. DESJEUX, M. K. WASUMA, AND A. D. BRYCESON. 2002. Visceral leishmaniasis: Current status of control, diagnosis and treatment, and a proposed research and development agenda. The Lancet Infectious Diseases 2: 494-501.
12. HERNÁNDEZ, D. E., N. RODRIGUEZ, M. WESSOLOSSKY, AND J. CONVIT. 1995. Visceral leishmaniais due to a Leishmania variant that shares kinetoplast DNA sequences with Leishmania brasiliensis and Leishmania mexicana in a patient infected with human immunodeficiency virus: Identification of the Leishmania species with the use of the polymerase chain reaction. Clinical Infectious Diseases 21: 701-702.
13. JIMENEZ, M. I., R. LÓPES-VÉLEZ, R. MOLINA, C. CAÑAVATE, AND J. ALVAR. 1996. HIV coinfection with a currently non-pathogenic flagellate. The Lancet 347: 264-265.
14. LAGUNA, F. 2003. Treatment of leishmaniasis in HIV-positive patients. Annals of Tropical Medicine and Parasitology 37: S135-S142.
15. LÓPEZ-VÉLEZ R., S. VIDELA, M. MÁRQUEZ, V. BOIX, M. E. JIMENEZ- MEJIAS, M. GORGOLAS, J. R. ARRIBAS, A. SALAS, F. LAGUNA, M. SUST, ET AL. 2004. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. Journal of Antimicrobial Chemotherapy 53: 540-543.
16. LYONS, S., H. VEEKAN, AND J. LONG. 2003. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Tropical Medicine and International Health 8: 733-739.
17. MIRA, J. A., J. E. CORZO, A. RIVERO, J. MACIAS, F. L. DE LEON, J. TORRE- CISNEROS, J. GOMES-MATEOS, R. JURADO, AND J. A. PINEDA. 2004. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus infected patients receiving highly active antiret-roviral therapy. American Journal of Tropical Medicine and Hygiene 70: 298-301.
18. MOLINA, I., V. FALCÓ, M. CRESPO, C. RIERA, E. RIBERA, A. CURRAN, J. CARRIO, M. DIAZ, S. VILLAR DEL SAZ, R. FISA, ET AL. 2007. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. Journal of Antimicrobial Chemotherapy 60: 837-842.
19. OLLIARO, P. L., P. J. GUERIN, S. GERSTL, A. A. HAASKJOLD, J. A. ROTTINGEN, AND S. SUNDAR. 2005. Treatment options for visceral leish-maniasis: A systematic review of clinical studies done in India, 1980-2004. The Lancet Infectious Diseases 5: 763-774.
20. PAREDES, R., J. MUNOZ, I. DIAZ, P. DOMINGO, M. GURGUI, AND B. CLOTET. 2003. Leishmaniasis in HIV infection. Journal of Postgraduate Medicine 49: 39-49.
21. PASQUAU, F., J. ENA, R. SANCHEZ, J. M. CUADRADO, C. AMADOR, J. FLORES, C. BENITO, C. REDONDO, J. LACRUZ, V. ABRIL, ET AL. 2005. Leishmaniasis as an opportunistic infection in HIV-infected patients: Determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterranean region. European Journal of Clinical Microbiology & Infectious Diseases 24: 411-418.
22. DE PAULA, A. A., A. V. M. SILVA, O. FERNANDES, AND A. M. JANSEN. 2003. The use of immunoblot analysis in the diagnosis of canine visceral leishmaniasis in an endemic area of Rio de Janeiro. Journal of Parasitology 89: 832-836.
23. PINTADO, V., AND R. LOPES-VELEZ. 2001. Visceral leishmaniasis associated with human immunodeficiency virus infection. Enfermeda-des Infecciosas y Microbiología Clínica 19: 353-357.
24. RABELLO, A., M. ORSINI, AND J. DISCH. 2003. Leishmania/HIV co-infection in Brazil: An appraisal. Annals of Tropical Medicine and Parasitology 97: S17-S28.
25. ROSENTHAL, E., P. MARTY, Y. LE FICHOUX, AND J. P. CASSUTO. 2000. Clinical manifestations of visceral leishmaniasis associated with HIV infection: A retrospective study of 91 French cases. Annals of Tropical Medicine and Parasitology 94: 37-42.
26. RUSSO, R., F. LAGUNA, R. LÓPEZ- VÉLEZ, F. J. MEDRANO, E. ROSENTHAL, B. CACOPARDO, AND L. NIGRO. 2003. Visceral leishmaniasis in those infected with HIV: Clinical aspects and other opportunistic infections. Annals of Tropical Medicine and Parasitology 97: S99-S105.
27. SASAKI, M. G. M., M. M. CARVALHO, M. L. S. FERREIRA, AND M. P. MACHADO. 1997. Cutaneous leishmaniasis coinfection in AIDS patients: Case report and literature review. The Brazilian Journal of Infectious Diseases 1: 142-144.
28. SINGH, S. 2006. New developments in diagnosis of leishmaniasis. Indian Journal of Medical Research 123: 311-330.
29. -, AND R. SIVAKUMAR. 2003. Recent advances in the diagnosis of leishmaniasis. Journal of Postgraduate Medicine 49: 55-60.
30. SIPSAS, N. V., AND J. BOLETIS. 2003. Fever, hepatosplenomegaly, and pancytopenia in a renal transplant recipient. Transplant Infectious Disease 5: 47-52.
31. TER HORST, R., S. M. COLLIN, K. RITMEIJER, A. BOGALE, AND R. N. DAVIDSON. 2008. Concordant HIV infection and visceral leishman-iasis in Ethiopia: The influence of antiretroviral treatment and other factors on outcome. Clinical Infectious Diseases 46: 1702-1709.
32. TREMBLAY, M., M. OLIVIER, AND R. BERNIER. 1996. Leishmania and the pathogenesis of HIV infection. Parasitology Today 12: 257-261.